Literature DB >> 27050695

Efficacy and Safety of Minoxidil 5% Foam in Combination With a Botanical Hair Solution in Men With Androgenic Alopecia.

Terrence C Keaney, Hanh Pham, Erika von Grote, Matthew H Meckfessel.   

Abstract

Androgenic alopecia (AGA) is the most common type of hair loss in men, characterized by hair miniaturization, hairline recession, and vertex balding. It affects approximately 50% of men, negatively affecting self-esteem and sociability. Topical minoxidil formulations are approved up to a 5% concentration for men, but patient adherence to treatment is challenged by gradual results that may be perceived as a lack of initial benefit. Herbal extracts, which are also believed to promote healthier-looking hair, have a long history of use in hair care formulations. The safety and efficacy of a twice-daily regimen of 5% minoxidil foam used in combination with a novel botanical hair solution was evaluated in a 12-week, multicenter, single-arm, open label study in 56 subjects with mild to moderate AGA. Assessments included investigator ratings of improvement and subject self-ratings of satisfaction. Investigator ratings indicated significant improvement in scalp hair coverage and perception of overall treatment benefit in as early as 4 weeks (P<.001). Subject self-ratings were significant for improved hair growth and hair appearance in as few as 4 weeks (P<.05). The regimen was well tolerated, and subjects indicated a high degree of satisfaction. Investigator and subject-assessed efficacy and subject satisfaction with this novel regimen provide clinicians with an effective treatment option for AGA that also provides a high level of patient satisfaction, which may help promote patient adherence to long-term treatment.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27050695

Source DB:  PubMed          Journal:  J Drugs Dermatol        ISSN: 1545-9616            Impact factor:   2.114


  3 in total

1.  Efficacy and Safety of a Topical Botanical in Female Androgenetic Alopecia: A Randomized, Single-Blinded, Vehicle-Controlled Study.

Authors:  Alexandros C Katoulis; Aikaterini I Liakou; Antigoni Alevizou; Stefanos Bonovas; Evangelia Bozi; Dimitra Kontogiorgi; Dimitrios Rigopoulos
Journal:  Skin Appendage Disord       Date:  2017-11-16

2.  Physcion, a novel inhibitor of 5α-reductase that promotes hair growth in vitro and in vivo.

Authors:  Zizhao Lao; Yaohua Fan; Yuhang Huo; Feng Liao; Rongwen Zhang; Bei Zhang; Ziyun Kong; Haishan Long; Jieliang Xie; Chuanlan Sang; Ludi Fu; Ji Lin; Yina Wu; Liangwen Yu; Geng Li
Journal:  Arch Dermatol Res       Date:  2021-02-26       Impact factor: 3.017

3.  Promotion of anagen, increased hair density and reduction of hair fall in a clinical setting following identification of FGF5-inhibiting compounds via a novel 2-stage process.

Authors:  Dominic Burg; Masakuni Yamamoto; Masato Namekata; Joseph Haklani; Koichiro Koike; Maria Halasz
Journal:  Clin Cosmet Investig Dermatol       Date:  2017-02-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.